Corporate Presentation

The presentation herein may contain forward looking statements by the management

of Best World International Ltd (BWI) that pertain to expectations for financial

performance of future periods vs past periods. Such forward looking statements

involve certain risks and uncertainties as they relate to future events. Actual results

may vary materially from those targeted, expected or projected due to various factors.

Such factors are, among others, general economic conditions, foreign exchange

fluctuations, competitive product and pricing pressures as well as changes in tax

regimes and regulatory developments. Such statements are not and should not be

construed as management’s representation on the future performance of BWI.

Therefore, the actual performance of BWI may differ significantly from expressions

provided herein. The reader is cautioned to not unduly rely on these forward-looking

statements.

Neither the Group nor its advisers and representatives shall have any liability

whatsoever for any loss arising, whether directly or indirectly, from any use or

distribution of this presentation or its contents.

This presentation is for information only and does not constitute an invitation or offer

to acquire, purchase or subscribe for shares in BWI.

• About Best World

• FY2015 Financial Highlights

• Strategy & Outlook

• Q&A

Content

Our Vision

To be a global leading

health and wellness

company dedicated to

creating products that

enhance the lives of our

customers.

About Best World

• Founded in 1990, Best World

International specializes in

– Premium skincare,

– Health Supplements

– Nutritional and wellness

products.

• Today, Best World is a key

regional player with a network

of over 402,000 independent

distributors and members in

the 12 markets we operate in.

About Best World

• In July 2004, Best World became

the first direct-selling company to

be public listed on the Singapore

Stock Exchange.

• Through our wholly owned

subsidiary in the PRC, we also

manufacture and distribute the

Aurigen line of supplements in

China through drugstores in 28

provinces of PRC.

About Our Direct Selling Model

• Marketing through extensive regional

network

• Sizeable member base with strong growth

ensures push of new and existing

products to drive top and bottom line

growth

• Unique system of training classes and

compensation scheme to effectively

engage members

• Member’s commission derived based on

sales

• Highly scalable with little capex required

as key costs are mainly related to

commissions

Product Concept

3rd Party

Manufacturing

Marketing

Tools

Direct Selling

Product

Registration

Overall Membership Growth

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

450,000

2010 2011 2012 2013 2014 2015

Membership (2010-2015)

Ideal model for each market

Direct Selling

Growth markets with track record and set regulations (e.g. Philippines, Taiwan)

Export

When market regulations are not clearly defined; appoint local

distributor as lead (e.g. China, Myanmar)

Manufacturing

Large mature markets with domestic demand (e.g. China, Japan, US, Europe)

Our Business Segments

Our Business Segments

Subsidiary

BW HQ

D

D D D

D

D D D

Direct-selling Export

BW HQ

Agent

Direct Selling Profit

Export Profit

Member price Export price

(a fraction of

member price)

• Founded in 1990

• Opening of first business centre in Malaysia in 1998

• Listed on SGX in 2004

• Entered into Thailand Market in 2004

• Expanded into Vietnam with new lifestyle center in

2005

• Expanded outside South East Asia with Hong Kong

Regional Center in 2006

• Expanded into Taiwan Market in 2006

• Grand launch of Indonesia Market in 2007

• Entered into Korea Market in 2009

• Ventured into Philippines in 2010

• Completed acquisition of Zhejiang SolidGold

Pharmaceutical Co., Ltd. in 2014

• Established a Joint Venture in Dubai, the United

Arab Emirates in 2016

Corporate Milestones

Our Markets

Our Brands

Our Brands

Our Awards

2009, 2008, 2015

FY2015

Financial

Highlights

Financial Review Overview

Revenue growth – slow but steady

• Incremental revenue from additional wholesale/

manufacturing segment

Stable financial margins

• Stable distribution expenses

S$’000 4Q2015 4Q2014 % Change

FY2015 FY2014 % Change

Revenue 40,945 24,957 64.1 101,672 75,265 35.1

Gross Profit

30,611 19,241 59.1 76,867 55,990 37.3

Gross Profit Margin 74.8% 77.1% (2.3p.p) 75.6% 74.4% 1.2p.p

Profit Before Tax 9,421 2,312 307.5 16,992 5,652 200.6

Attributable Profit to

Owners of the Parent

Company

3,714 2,052 81.0 10,104 4,054 149.2

Net Profit Margin

9.1% 8.2% 0.9p.p 9.9% 5.4% 4.5p.p

Earnings Per Share

(Cents)

1.69 0.93 81.7 4.59 1.86 146.6

Income Statement Highlights

P.P denotes percentage points

NM denotes not meaningful

Direct Selling 79%

Export 14%

Manufacturing/

Wholesale 7%

2015

Direct Selling Export Manufacturing/Wholesale

80%

11% 9%

2014

Revenue by Business Segmentation

Singapore 7.3%

China 19.4%

Indonesia 6.4%

Taiwan 55.5%

Philippines 2.8%

Others 8.6%

2015

Singapore China Indonesia

Taiwan Phiippines Others

11.7%

17.2%

3.8% 30.2%

24.6%

12.5%

2014

Revenue by Region

Revenue by Products

Skin Care 70%

Health Supplments

11%

Weight Management

16%

Others 3%

S$’000 As at 31 Dec 2015 As at 31 Dec 2014

Cash & Cash Equivalents 47,247 40,975

Non-Current Assets 17,804 17,068

Current Assets 76,599 67,053

Non-Current Liabilities 2,321 3,006

Current Liabilities 30,097 25,658

Net Gearing Net cash Net cash

Balance Sheet Highlights

Strong Balance Sheet

supported by healthy cash position and low gearing ratio

Dividend Policy

at least 30% of profit after tax

Strategy

& Outlook

Growth Opportunities in Key Markets

Taiwan China Indonesia

• Ranked among the Top 15

Direct Selling brands in

Taiwan in 2015 by the Fair

Trade Commission of the

Republic of China (中華民國公平交易委員會)

• The number one in Taiwan,

Amway, has a market

share of NT$11.7B

• Opening of third RC in

Southern Taiwan as well

as leverage on social

media to boost top line

• Laid the groundwork in

preparation for its direct

selling market through:

- Registering all of its

products

- An established network

via export agents

- Good understanding of

the different cultures in

key provinces

• Top leaders trained in

Taiwan will be forerunners

in China’s direct selling

market

• Positive results underscore

new motivated leader

distributors that have been

acquired

• Continues to be an exciting

market for the Group’s

weight management

products

Growth Strategy

Tap into organic growth opportunities to gain access to new markets and/or new distribution channels

Attain exclusivity to new products/services

Tap into upstream value chain of business which are synergistic to ours

1

2

3

Market Outlook

• Direct selling remains uniquely poised for expansion in both advanced and emerging markets

- Posted 6.5% three year CAGR from 2011 to 2014

• China and other Asian countries, plus

emerging markets in Latin America, are fuelling much of the industry’s growth.

- Emerging markets as a whole produced 45% of all 2014 direct retail sales, a 7% increase from 2010 to 2014

• Beauty, personal care and wellness

products are the most popular globally and regionally

Information source: directsellingnews.com (website was designed to offer a comprehensive global view of the direct selling industry.)

Group Outlook • Continue to build on growth momentum in

key markets

• Application for direct selling license in China

is in progress – potential market demand

may increase in multiple folds

• Cautiously optimistic of a positive FY2016

performance, due to continual growth in key

markets like Taiwan, China and Indonesia as

well as the launch of several new products in

the next few quarters

Investment Merits

Value Proposition

Established network of distributors

Strong range of products backed by

good reviews

Growth Prospects

Growing revenue driven by momentum

in key markets; awaiting license from

China

Stable margins due to economies of

scale and operational efficiencies

Strong Balance Sheet

Healthy cash position with low

gearing

Dividend policy of at least 30% of net profit after tax

Thank You!

Q&A

Appendix

Taiwan Direct-Selling Market (2015) Rank Company Sales Figure

1 Amway NT$11.7N

2 Pro-Partner NT$7.1B

3 Melaleuca *NT$4.8B

4 Herbalife *NT$4.6B

5 Nu Skin *NT$4.5B

6 Market America *NT$4.3B

7 Total Swiss International Group NT$4.2B

8 Jeunesse Global NT$2.7B

9 E. Excel NT$2.3B

10 Avon Products *NT$2.1B

*= Estimated Information extracted from: Power Networking Monthly magazine

Best World Products Before VS. After